妊娠検査機器市場 - 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、技術別、流通チャネル別、地域別、競合、2019年～2029年

妊娠検査機器の世界市場規模は2023年に15億3,000万米ドルで、予測期間中のCAGRは5.21%で2029年には20億7,000万米ドルに達すると予測されています。

世界の妊娠検査機器市場は主に、その拡大を形成しているいくつかの重要な要因によって牽引されています。主要な促進要因の1つは、妊娠の早期発見に対する認識と嗜好の高まりであり、信頼性が高く使いやすい検査ソリューションに対する需要の高まりを促しています。妊娠検査機器における高感度検査、迅速結果技術、デジタル統合などの技術的進歩は、ユーザーの正確性と利便性を高めています。さらに、ヘルスケアサービスや小売チャネルの拡大により、これらの機器の入手可能性やアクセス性が高まっていることも、市場成長に大きく寄与しています。プライバシーと使いやすさを提供する在宅検査の動向の高まりも需要を促進しています。さらに、リプロダクティブヘルスに関する消費者教育の増加や、結果の追跡・管理のためのモバイルアプリケーションの統合が、市場の拡大を支えています。これらの要因が進化し続けるにつれて、世界の妊娠検査機器市場は大幅な成長と革新を遂げ、多様化して拡大する消費者層のニーズを満たすことが期待されます。

市場促進要因

妊娠検査機器の技術的進歩の高まり

計画外の妊娠率の上昇

妊娠検査機器の認知度とアクセシビリティの向上

主な市場課題

妊娠検査機器を取り巻く倫理的配慮

妊娠検査機器における健康と安全への懸念の高まり

妊娠検査キットの適応率の低さ

主要市場動向

妊娠検査機器における早期発見の需要の高まり

家庭内妊娠検査キットの需要急増

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の妊娠検査機器市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別（尿ベース、血液ベース）
  • 技術別（ラインインジケーター、デジタルテスト）
  • 流通チャネル別（小売薬局、オンライン薬局、病院薬局）
  • 企業別（2023年）
  • 地域別
• 市場マップ

第6章 北米の妊娠検査機器市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別
  • 技術別
  • 流通チャネル別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の妊娠検査機器市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別
  • 技術別
  • 流通チャネル別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の妊娠検査機器市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別
  • 技術別
  • 流通チャネル別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の妊娠検査機器市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別
  • 技術別
  • 流通チャネル別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの妊娠検査機器市場の展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別
  • 技術別
  • 流通チャネル別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト
  • トルコ

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併および買収
• 製品の発売
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Abbott Laboratories
• SPD Swiss Precision Diagnostics GmbH
• BioMerieux SA
• Cardinal Health Inc.
• QuidelOrtho Corporation
• Germaine Laboratories Inc.
• Mankind Pharma Ltd.
• Piramal Enterprises Ltd.
• Procter & Gamble Co.
• CLIAwaived, Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Pregnancy Testing Devices Market was valued at USD 1.53 billion in 2023 and is expected to reach USD 2.07 billion by 2029 with a CAGR of 5.21% during the forecast period. The global pregnancy testing devices market is primarily driven by several key factors that are shaping its expansion. One of the major drivers is the increasing awareness and preference for early detection of pregnancy, which is prompting a higher demand for reliable and user-friendly testing solutions. Technological advancements in pregnancy testing devices, such as the development of highly sensitive tests, rapid result technologies, and digital integrations, are enhancing accuracy and convenience for users. Additionally, the growing availability and accessibility of these devices due to expanded healthcare services and retail channels contribute significantly to market growth. The rising trend of home-based testing, which offers privacy and ease of use, is also fueling demand. Furthermore, increasing consumer education on reproductive health and the integration of mobile applications for tracking and managing results are supporting the market's expansion. As these factors continue to evolve, the global pregnancy testing devices market is expected to witness substantial growth and innovation, meeting the needs of a diverse and expanding consumer base.

Key Market Drivers

Growing Technological Advancements in Pregnancy Devices

Advancements in technology have revolutionized the pregnancy testing devices market, leading to significant improvements in sensitivity, accuracy, and user experience. Modern home pregnancy test kits now boast enhanced capabilities to detect lower levels of human chorionic gonadotropin (hCG), the hormone indicative of pregnancy, enabling earlier and more reliable detection. Digital pregnancy tests have emerged with intuitive digital displays that provide clear "Pregnant" or "Not Pregnant" results, eliminating the ambiguity associated with traditional line-based tests. Moreover, integration with mobile applications allows users to track fertility cycles, receive personalized health insights, and securely store test results, enhancing overall user engagement and convenience. Rapid point-of-care testing technologies have also advanced, offering healthcare professionals and individuals quick results within minutes, crucial for timely decision-making in clinical settings.

Additionally, manufacturers continue to innovate by improving usability with ergonomic designs, larger result windows, and environmentally friendly materials, addressing both consumer preferences and sustainability concerns. For instance, the femtech company Pharmista Technologies is developing an eco-friendly pregnancy test, which can be used many times. The company has now been admitted to SmiLe's incubator program. These technological advancements not only meet the increasing demand for accurate and accessible pregnancy testing solutions but also propel the market forward, shaping the future of reproductive healthcare consumer products.Moreover, recent advancements in the global pregnancy test kits market have introduced new products capable of early detection, detecting pregnancy up to five to six days before a missed period.

This capability has significantly boosted the popularity of these test kits. Vendors offering such innovative products are poised to drive substantial growth in the industry moving forward. The increasing demand for these test kits is driven by the convenience they offer in determining pregnancy status without having to wait for a missed period. This technology is particularly appealing to women who have recently engaged in unprotected intercourse, making them a key target demographic for these advanced pregnancy test kits.

Rising Rate of Unplanned Pregnancies

Globally, approximately half of all pregnancies each year are unintended, highlighting a significant public health concern. Governments are increasingly focusing on promoting awareness about pregnancy testing as a preventive measure amidst rising rates of unplanned pregnancies and abortions among adolescent and adult women. Pregnancy testing kits play a crucial role in these initiatives, serving as a cornerstone in efforts to educate and empower individuals about family planning. According to the World Family Planning 2022 report, approximately 41 countries have achieved high contraceptive use rates among women seeking to avoid pregnancies, with Sub-Saharan Africa alone contributing around 22 of these countries. This widespread adoption of modern contraceptives underscores the importance of pregnancy testing devices in supporting effective family planning strategies.

Moreover, as knowledge about unintended pregnancies grows among women of various age groups, including adolescents and mothers, there is an increasing demand for pregnancy test kits. These kits are instrumental in empowering individuals to take proactive steps in family planning and avoiding pregnancies that are not desired. This rising demand reflects a broader trend towards greater reproductive health awareness and the critical role of accessible and reliable pregnancy testing solutions in achieving reproductive health goals.

Rising Awareness and Accessibility of Pregnancy Testing Devices

Rising awareness and improved accessibility are pivotal factors shaping the pregnancy testing devices market. As awareness about the benefits of early pregnancy detection grows, more women are inclined to utilize these devices. Early detection not only allows for timely medical consultation and prenatal care but also empowers women to make informed decisions about their reproductive health. This increased awareness is often driven by educational campaigns, healthcare initiatives, and the dissemination of information through various media channels. Moreover, growing awareness by the various government for the comprehensive and quality antenatal care is another significant reason for the growth of market. For instance, The Pradhan Mantri Surakshit Matritva Abhiyan has been launched by the Ministry of Health & Family Welfare (MoHFW), Government of India. The program aims to provide assured, comprehensive and quality antenatal care, free of cost, universally to all pregnant women on the 9th of every month.

Moreover, accessibility also plays a crucial role in expanding the market reach of pregnancy testing devices. These devices are now widely available in pharmacies, supermarkets, and convenience stores, making them easily accessible to consumers. Moreover, the proliferation of online platforms has further enhanced accessibility, allowing individuals to purchase test kits discreetly and conveniently from the comfort of their homes. Online availability also facilitates access in remote or underserved regions where access to physical stores may be limited. So, the combination of rising awareness and enhanced accessibility has contributed to a broader acceptance and adoption of pregnancy testing devices across diverse demographics. This trend not only benefits consumers by providing greater convenience and privacy but also drives market growth by expanding the consumer base. As technology continues to advance and awareness campaigns persist, the pregnancy testing devices market is expected to further evolve, meeting the increasing demand for reliable and accessible reproductive health solutions worldwide.

Key Market Challenges

Ethical Consideration Surrounding Pregnancy Testing Devices

Ethical considerations surrounding pregnancy testing devices encompass several key areas that manufacturers and healthcare providers must navigate thoughtfully. Privacy concerns are paramount, as these devices involve sensitive personal information regarding reproductive health. Manufacturers need to ensure that their products adhere to strict data protection regulations, safeguarding the confidentiality of users' test results and personal information. This includes secure handling of data both offline and online, especially with the integration of digital platforms and mobile applications.

Moreover, informed consent is another critical ethical issue. Users must be adequately informed about how pregnancy testing devices work, the accuracy of results, potential implications of the results, and any associated risks. Clear and accessible information about the limitations and interpretation of test results is essential to empower users to make informed decisions about their reproductive health. Healthcare providers play a crucial role in ensuring that patients understand these aspects before and after using pregnancy testing devices, providing appropriate counseling and support.

Growing Health and Safety Concerns in the Pregnancy Testing Devices

Ensuring health and safety in the pregnancy testing device market is paramount for maintaining consumer trust and regulatory compliance. Accuracy is crucial, as false positives or negatives can have significant health implications. A false negative might delay necessary prenatal care, while a false positive can cause undue stress and anxiety. The accuracy of pregnancy tests depends on their sensitivity and specificity, which reflect their ability to detect human chorionic gonadotropin (hCG) and distinguish it from other substances. User errors, such as misinterpreting results or improper sample collection, and variability in manufacturing quality can also affect accuracy. Regulatory standards from bodies like the FDA and CE mandate rigorous validation through clinical trials and adherence to quality management systems such as ISO 13485. Additionally, manufacturers must ensure that testing materials are non-toxic and safe, with stringent quality control processes to prevent contamination. Proper packaging, clear usage instructions, and safety warnings are essential to mitigate user errors and ensure safe handling. Moreover, compliance with safety regulations, including guidance on safe disposal and environmental impact, further enhances the safety and effectiveness of pregnancy testing devices. Regular safety testing and adherence to best practices in manufacturing and usage are crucial for upholding the reliability and trustworthiness of these products.

Low Adaptation Rate of Pregnancy Test Kits

Insufficient knowledge about pregnancy test kits among women poses a significant hurdle to the growth of the pregnancy testing devices market in the forecast period. This lack of awareness extends to women with conditions like Polycystic Ovary Syndrome (PCOS), where irregular ovulation patterns can complicate the accuracy of ovulation prediction kits, further restraining market expansion. Moreover, the field of perinatology faces numerous challenges in modern times, including complex issues such as congenital heart conditions, kidney malfunctions, and developmental abnormalities in fetuses. Effective testing during pregnancy plays a crucial role in identifying and managing these risks. For instance, advanced pregnancy testing devices are pivotal in monitoring maternal health and detecting abnormalities early, thereby facilitating timely medical interventions. Moreover, in cases where immunotherapy treatment is necessary due to autoimmune disorders, precise and timely pregnancy testing is essential. Ensuring accurate results from pregnancy testing devices enables healthcare providers to make informed decisions regarding treatment strategies and maternal care, minimizing risks associated with autoimmune reactions during pregnancy.

Key Market Trends

Growing Demand for Early Detection in Pregnancy Testing Devices

There is a notable trend towards increased demand for early detection capabilities in pregnancy testing devices, driven by growing awareness and evolving consumer preferences. Modern advancements in technology have enabled the development of pregnancy tests that can detect pregnancy markers such as human chorionic gonadotropin (hCG) even before a missed period, addressing women's desire for early confirmation of pregnancy. Moreover, this trend is particularly significant as it aligns with changing societal norms and healthcare behaviors. Women are increasingly proactive about their reproductive health, seeking to confirm pregnancy status as early as possible to facilitate timely prenatal care and informed decision-making. Early detection also allows individuals to plan for pregnancy or consider necessary adjustments in lifestyle and healthcare management early on.

Furthermore, technological innovations play a pivotal role in meeting this demand. Newer pregnancy testing devices offer enhanced sensitivity and accuracy, detecting lower levels of hCG in urine samples within a few days post-conception. These advancements not only cater to consumer preferences for early results but also contribute to the convenience and reliability associated with home-based testing. Additionally, the trend towards early detection is bolstered by educational campaigns and healthcare initiatives that emphasize the importance of timely pregnancy confirmation. This includes promoting awareness about the benefits of early prenatal care and the potential risks associated with delayed detection.

As this trend continues to shape the pregnancy testing devices market, manufacturers are likely to focus on further enhancing the performance and user experience of their products. This may involve ongoing research into novel detection technologies, integration with digital health platforms for enhanced connectivity, and efforts to address affordability and accessibility barriers globally. Overall, the rising demand for early detection reflects a broader shift towards proactive reproductive healthcare practices, driving innovation and growth in the market for pregnancy testing devices.

Surging Demand of In-Home Pregnancy Testing Kits

There is a significant trend towards the growth of home pregnancy testing kits, driven by their increasing popularity and accessibility among consumers seeking convenient and private pregnancy confirmation solutions. Home testing kits have become preferred over traditional clinical visits for several reasons, including convenience, ease of use, and the ability to maintain privacy during the testing process. The convenience offered by home pregnancy testing kits is a key factor driving their adoption. These kits are readily available over the counter at pharmacies, supermarkets, and online retailers, allowing individuals to purchase them easily and use them at their convenience, without the need for scheduling appointments or visiting healthcare facilities. This accessibility is particularly appealing to busy individuals and those who prefer to manage their reproductive health privately.

Moreover, home pregnancy testing kits are designed to be user-friendly, with clear instructions and straightforward result interpretation. Many modern kits offer digital displays or clear result windows, reducing the likelihood of misinterpretation compared to traditional line-based tests. This simplicity enhances user confidence in the accuracy of results obtained at home. Additionally, privacy is another significant advantage of home pregnancy testing kits. By conducting the test at home, individuals can maintain confidentiality and discretion regarding their reproductive health status. This privacy aspect is particularly valued in cultures or situations where discussing or seeking medical assistance for reproductive issues may be sensitive or stigmatized.

Segmental Insights

Product Type Insights

Based on the product type, the urine-based category is projected to experience rapid growth during the forecast period due to its unparalleled convenience, accessibility, and user-friendly nature. These tests are widely available over the counter in pharmacies, supermarkets, and online, allowing individuals to purchase them easily and conduct tests in the privacy of their homes without the need for a healthcare provider's visit. This accessibility, coupled with their affordability compared to laboratory-based tests or clinical visits, makes urine-based tests accessible to a broad demographic, including those with limited financial resources. Furthermore, urine-based pregnancy tests are designed to be straightforward, with clear instructions and rapid results typically available within minutes. Advances in technology have enhanced their sensitivity and accuracy, enabling early detection of pregnancy hormones like human chorionic gonadotropin (hCG) even before a missed period in some cases. The reliability of these tests has significantly contributed to their widespread acceptance and use among consumers globally. Additionally, urine-based tests offer a high level of privacy and discretion, allowing users to maintain confidentiality regarding their reproductive health status. Cultural and social acceptance further supports the dominance of urine-based pregnancy tests, making them a preferred choice for individuals seeking reliable, convenient, and private pregnancy confirmation solutions.

Regional Insights

North America emerged as the dominant region in the global Pregnancy Testing Devices market in 2023. This is due to its advanced healthcare infrastructure, which ensures widespread accessibility of these devices across hospitals, clinics, pharmacies, and online platforms. The region's proactive healthcare practices emphasize early detection, driving demand for advanced and accurate testing technologies. Cultural acceptance and integration of pregnancy testing into routine healthcare contribute to high consumer adoption rates. Stringent regulatory standards further bolster confidence in the reliability and safety of these devices. Additionally, North America is home to leading healthcare and pharmaceutical companies that innovate continuously, developing state-of-the-art pregnancy testing technologies to meet the evolving needs of consumers. In Canada, unintended pregnancies in adolescents significantly impact young women, their families/children, and society. For instance, according to a research study by Amanda Black et al., published in the Journal of Obstetrics and Gynaecology Canada, in May 2019, among Canadian adolescents, there were more than 39,000 unintended pregnancies (UPs) annually. These factors collectively underscore North America's leadership in the global market for pregnancy testing devices.

Key Market Players

• Abbott Laboratories
• SPD Swiss Precision Diagnostics GmbH
• BioMerieux SA
• Cardinal Health Inc.
• QuidelOrtho Corporation
• Germaine Laboratories, Inc.
• Mankind Pharma Ltd.
• Piramal Enterprises Ltd.
• Procter & Gamble Co.
• CLIAwaived, Inc.

Report Scope:

In this report, the Global Pregnancy Testing Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pregnancy Testing Devices Market, By Product Type:

• Urine based
• Blood based

Pregnancy Testing Devices Market, By Technology:

• Line Indicator
• Digital Test

Pregnancy Testing Devices Market, By Distribution Channel:

• Retail Pharmacies
• Online Pharmacies
• Hospital Pharmacies

Pregnancy Testing Devices Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pregnancy Testing Devices Market.

Available Customizations:

Global Pregnancy Testing Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Pregnancy Testing Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Urine based, Blood based)
  • 5.2.2. By Technology (Line Indicator, Digital Test)
  • 5.2.3. By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies)
  • 5.2.4. By Company (2023)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Pregnancy Testing Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Technology
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pregnancy Testing Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Mexico Pregnancy Testing Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Canada Pregnancy Testing Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Distribution Channel

7. Europe Pregnancy Testing Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Technology
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Pregnancy Testing Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. Germany Pregnancy Testing Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Pregnancy Testing Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Pregnancy Testing Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Pregnancy Testing Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Pregnancy Testing Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Technology
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pregnancy Testing Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Pregnancy Testing Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. South Korea Pregnancy Testing Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. Japan Pregnancy Testing Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Pregnancy Testing Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Distribution Channel

9. South America Pregnancy Testing Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Technology
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pregnancy Testing Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Argentina Pregnancy Testing Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. Colombia Pregnancy Testing Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Pregnancy Testing Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Technology
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pregnancy Testing Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Saudi Arabia Pregnancy Testing Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. UAE Pregnancy Testing Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Distribution Channel
  • 10.3.4. Egypt Pregnancy Testing Devices Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Product Type
      • 10.3.4.2.2. By Technology
      • 10.3.4.2.3. By Distribution Channel
  • 10.3.5. Turkey Pregnancy Testing Devices Market Outlook
    • 10.3.5.1. Market Size & Forecast
      • 10.3.5.1.1. By Value
    • 10.3.5.2. Market Share & Forecast
      • 10.3.5.2.1. By Product Type
      • 10.3.5.2.2. By Technology
      • 10.3.5.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Abbott Laboratories
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. SPD Swiss Precision Diagnostics GmbH
• 14.3. BioMerieux SA
• 14.4. Cardinal Health Inc.
• 14.5. QuidelOrtho Corporation
• 14.6. Germaine Laboratories Inc.
• 14.7. Mankind Pharma Ltd.
• 14.8. Piramal Enterprises Ltd.
• 14.9. Procter & Gamble Co.
• 14.10. CLIAwaived, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer